Curran, Desmond; Matthews, Sean; Rowley, Scott-D; Young, Jo-Anne-H; Bastidas, Adriana; Anagnostopoulos, Achilles; Barista, Ibrahim; Chandrasekar, Pranatharthi-Haran; Dickinson, Michael; El-Idrissi, Mohamed; Heras-Fernando, Inmaculada; Milliken, Samuel-T; Monserrat-Coll, Jorge; Navarro-Matilla, María-Belen; Oostvogels, Lidia; Piatkowska-Jakubas, Beata; Quiel, Dimas; Sabry, Waleed; Schwartz, Stefan; Selleslag, Dominik-L-D; Sullivan, Keith-M; Theunissen, Koen; Yegin, Zeynep-Arzu; Yeh, Su-Peng; Zaja, Francesco; Szer, Jeff; Sauboin, Christophe; Marcos, Camelia; Heineman, Thomas-C
(ELSEVIER SCIENCE INC, 2019-12)
Herpes zoster (HZ) can have a substantial impact on quality of life (QoL). The vaccine efficacy (VE) of a recombinant zoster vaccine (RZV) was 68.2% (95% confidence interval [CI], 55.6% to 77.5%) in a phase 3 study in adult ...